Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.
Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model.
Febs Open Bio
Sarcar, Bhaswati B; Gimbrone, Nicholas T NT; Wright, Gabriela G; Remsing Rix, Lily L LL; Gordian, Edna R ER; Rix, Uwe U; Chiappori, Alberto A AA; Reuther, Gary W GW; Santiago-Cardona, Pedro G PG; Muñoz-Antonia, Teresita T; Cress, William Douglas WD